AIDoc

The company's core product is an "Always-on AI" platform, known as the aiOS™ (AI Operating System), which integrates into existing hospital picture archiving and communication systems (PACS) and workflows. This system runs in the background, analyzing medical images from CT scans and X-rays to flag time-sensitive conditions such as intracranial hemorrhage, pulmonary embolism, spine fractures, and vessel occlusions. Upon detection, it alerts radiologists and relevant clinical teams, enabling faster diagnosis and treatment. Aidoc's business model is based on providing its platform to healthcare facilities, including hospitals, teleradiology groups, and outpatient imaging centers, which enhances their operational efficiency and patient outcomes. The platform is designed to be a comprehensive enterprise solution, capable of integrating both Aidoc's proprietary algorithms and third-party AI applications.

Aidoc has achieved significant regulatory milestones, holding numerous FDA clearances and CE marks for its suite of algorithms, making it a prominent player in the clinical AI space. The company has also secured substantial funding from investors, including General Catalyst, Square Peg, and NVentures (NVIDIA's investment arm), to fuel its growth and the development of its next-generation foundation model, CARE™. This new technology is designed to accelerate the creation of new algorithms by understanding medical imaging as a broad domain, moving from tackling one disease at a time to a more comprehensive and faster development cycle.